Volume 16, Issue 2, Pages (February 2002)

Slides:



Advertisements
Similar presentations
Retrovirally Transduced CD34++ Human Cord Blood Cells Generate T Cells Expressing High Levels of the Retroviral Encoded Green Fluorescent Protein Marker.
Advertisements

Overexpression of suppressor of cytokine signaling-1 impairs pre-T-cell receptor–induced proliferation but not differentiation of immature thymocytes by.
Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Notch signaling induces cytoplasmic CD3ϵ expression in human differentiating NK cells by Magda De Smedt, Tom Taghon, Inge Van de Walle, Greet De Smet,
Volume 6, Issue 1, Pages (January 1997)
Volume 4, Issue 6, Pages (June 2009)
by Shawn W. Cochrane, Ying Zhao, Robert S. Welner, and Xiao-Hong Sun
Volume 28, Issue 2, Pages (February 2008)
Volume 8, Issue 1, Pages (January 1998)
Volume 12, Issue 10, Pages (September 2015)
Volume 6, Issue 4, Pages (April 1997)
miR-150-Mediated Foxo1 Regulation Programs CD8+ T Cell Differentiation
A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells  Aixin Yu, Linjian Zhu, Norman H. Altman,
Christine V. Ichim, Džana D
Requirement for the Thymus in αβ T Lymphocyte Lineage Commitment
IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis
Georges Lacaud, Leif Carlsson, Gordon Keller  Immunity 
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Lck Activity Controls CD4/CD8 T Cell Lineage Commitment
Differential Roles of ERK and p38 MAP Kinase Pathways in Positive and Negative Selection of T Lymphocytes  Takehiko Sugawara, Tetsuo Moriguchi, Eisuke.
Volume 33, Issue 4, Pages (October 2010)
Volume 12, Issue 2, Pages (August 2003)
Volume 29, Issue 1, Pages (July 2008)
Volume 25, Issue 5, Pages (November 2006)
Kenichi Miharada, Valgardur Sigurdsson, Stefan Karlsson  Cell Reports 
Susan V Outram, Alberto Varas, Carmen V Pepicelli, Tessa Crompton 
Volume 28, Issue 6, Pages (June 2008)
TCR Signal Strength Influences αβ/γδ Lineage Fate
Volume 29, Issue 2, Pages (August 2008)
Volume 36, Issue 2, Pages (February 2012)
Skint-1 Identifies a Common Molecular Mechanism for the Development of Interferon-γ- Secreting versus Interleukin-17-Secreting γδ T Cells  Gleb Turchinovich,
Volume 39, Issue 6, Pages (December 2013)
Volume 7, Issue 4, Pages (October 2010)
Volume 33, Issue 4, Pages (October 2010)
Volume 16, Issue 5, Pages (May 2002)
Volume 28, Issue 4, Pages (April 2008)
Identification of a T Lineage-Committed Progenitor in Adult Blood
Volume 13, Issue 2, Pages (August 2000)
Volume 7, Issue 6, Pages (December 2016)
Volume 9, Issue 5, Pages (November 1998)
Volume 14, Issue 2, Pages (February 2001)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 22, Issue 3, Pages (March 2005)
Kai M Müller, Carrie J Luedecker, Mark C Udey, Andrew G Farr  Immunity 
Volume 24, Issue 1, Pages (January 2006)
Volume 6, Issue 7, Pages (July 1996)
STAT3 Is Required for Flt3L-Dependent Dendritic Cell Differentiation
Volume 9, Issue 4, Pages (October 2011)
Common Developmental Pathway for Primitive Erythrocytes and Multipotent Hematopoietic Progenitors in Early Mouse Development  Toshiyuki Yamane, Aya Washino,
Volume 14, Issue 3, Pages (March 2001)
Volume 19, Issue 1, Pages (July 2003)
Rodney P. DeKoter, Hyun-Jun Lee, Harinder Singh  Immunity 
Volume 33, Issue 5, Pages (November 2010)
Volume 33, Issue 1, Pages (July 2010)
Thomas M. Schmitt, Juan Carlos Zúñiga-Pflücker  Immunity 
Tomokatsu Ikawa, Hiroshi Kawamoto, Lilyan Y.T. Wright, Cornelis Murre 
Volume 22, Issue 5, Pages (May 2005)
Volume 25, Issue 1, Pages (July 2006)
Volume 31, Issue 6, Pages (December 2009)
TCR Signal Strength Influences αβ/γδ Lineage Fate
Volume 20, Issue 6, Pages (June 2004)
Volume 17, Issue 2, Pages (August 2002)
Volume 14, Issue 1, Pages (January 2001)
Volume 10, Issue 5, Pages (May 1999)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 6, Issue 4, Pages (April 1997)
Volume 31, Issue 4, Pages (October 2009)
Volume 17, Issue 5, Pages (November 2002)
The Role of Erk1 and Erk2 in Multiple Stages of T Cell Development
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
Presentation transcript:

Volume 16, Issue 2, Pages 285-296 (February 2002) Constitutive Expression of PU.1 in Fetal Hematopoietic Progenitors Blocks T Cell Development at the Pro-T Cell Stage  Michele K Anderson, Angela H Weiss, Gabriela Hernandez-Hoyos, Christopher J Dionne, Ellen V Rothenberg  Immunity  Volume 16, Issue 2, Pages 285-296 (February 2002) DOI: 10.1016/S1074-7613(02)00277-7

Figure 1 Western Blot Analyses of PU.1 Protein Expression Protein blots were probed with anti-PU.1 antibody, stripped, and probed again with anti-Sp1 antibody. (A) Nuclear extracts from Rag-2−/− thymocytes (RT; lane 1), representing only pro-T cells, and C57Bl/6 thymocytes (NT; lane 2), representing mostly DP pre-T cells. (B) E14.5 and E15.5 fetal thymocyte whole-cell extracts at full strength (lanes 1 and 3) and diluted by 1/3 (lanes 2 and 4). (C) Mock-transduced (3 × 105 cells, lane 1) or transduced fetal liver cells (GFP-FL, LZRS as a control versus PU.1-FL) cultured for 72 hr with IL7 and SCF, and then sorted, at 9 × 105 cells (lanes 2 and 5), 3 × 105 cells (lanes 3 and 6), or 1 × 105 cells (lanes 4 and 7). (D) Diagram of T cell development, showing that lineage commitment and downregulation of PU.1 mRNA occur at the DN2 to DN3 transition, whereas β selection occurs at the DN3 to DN4 transition. The box indicates the DN subsets that constitute the pro-T cell stage. Immunity 2002 16, 285-296DOI: (10.1016/S1074-7613(02)00277-7)

Figure 2 Effects of PU.1 and HEB-Alt on Fetal Liver Precursor Differentiation in Fetal Thymic Organ Culture Fetal liver precursors infected with the Lazarus retrovirus as a control (LZRS-GFP), a PU.1-encoding LZRS retrovirus (PU.1-GFP), or an HEB-Alt-encoding LZRS retrovirus (HEB-GFP) were differentiated in fetal thymus organ culture (FTOC) and analyzed for expression of differentiation markers by FACS analysis. GFP versus Ly5.1 expression gated on live cells after (A) 8 days and (B) 13 days in FTOC. The percentages of GFP+ cells are indicated. (C) and (D) are gated on GFP+ cells at day 13 of FTOC. The CD3+TCRβ−cells represent γδ T cells. (E) provides a diagram of T cell differentiation from hematopoietic stem cells (HSC) and indicates the timing of the PU.1 block. Broken circles indicate cell populations lost in the presence of retroviral PU.1. The thick bar indicates a complete block in differentiation. Immunity 2002 16, 285-296DOI: (10.1016/S1074-7613(02)00277-7)

Figure 3 Effects of PU.1 Expression on Early T Cell Development Fetal liver precursors infected with the LZRS retrovirus as a control (LZRS-GFP) or a PU.1-encoding retrovirus (PU.1-GFP) were differentiated in fetal thymus organ culture for 1 week and analyzed for expression of GFP, CD44, and CD25 by FACS analysis. (A) CD44 versus CD25 expression gated on GFP+ cells. (B) Analysis of retroviral expression level as a function of developmental stage. Abbreviations: MFI, mean GFP fluorescence intensity; DN1, CD44+CD25−; DN2, CD44+CD25+; DN3, CD44−CD25+. (C) Diagram of T cell development with the early subsets expanded into three distinct populations. Broken circles indicate cell populations lost in the presence of retroviral PU.1. The thick bar indicates a complete block in differentiation, and the thin broken bar indicates partial inhibition as inferred from lower GFP fluorescence levels in surviving cells. Immunity 2002 16, 285-296DOI: (10.1016/S1074-7613(02)00277-7)

Figure 4 Expression of the Non-DNA Binding PU.1-215 Mutant Does Not Inhibit T Cell Development Fetal liver precursors were infected with either a PU.1-encoding retrovirus (PU.1-WT-GFP) or a mutant PU.1-encoding retrovirus (PU.1-215-GFP) that cannot bind DNA. GFP+ cells were sorted, differentiated in fetal thymic organ culture, and then analyzed by FACS after (A) 1 week or (B) 2 weeks. All plots in (A) are gated on GFP+ cells. The upper plots in (B) are gated on live cells, whereas the lower plots are gated on GFP+ cells. The pro-T cells in (A) are represented by the CD25+Thy-1+ population. Quadrant percentiles are indicated. Immunity 2002 16, 285-296DOI: (10.1016/S1074-7613(02)00277-7)

Figure 5 Effects of PU.1 Expression on B and Myeloid Lineage Cells Several representative experiments are shown. Fetal liver precursors infected with the LZRS retrovirus as a control (LZRS-GFP) or a PU.1-encoding retrovirus (PU.1-GFP) were differentiated in (A) fetal thymus organ culture (FTOC) plus IL-7 and stem cell factor for 7 days, (B) conventional FTOC (no cytokines added) for 8 days, or (C, F, and G) high oxygen submersion (HOS) FTOC culture plus IL-7, IL-3, and SCF for (C) 9 or (E–G) 10 days, and then analyzed by flow cytometry. All samples are gated on GFP+ cells except (E), which shows the percentages of GFP+ cells under HOS conditions using a live scatter gate. Percentages are indicated for each quadrant. (E) Absolute number of GFP+ cells per lobe in the categories listed. The FACS analyses in (E)–(G) contain pools of 1 1/2 lobes each. (H) Diagram of effects of PU.1 on T cell, B cell, and macrophage fate choices. Broken circles indicate cell populations lost in the presence of retroviral PU.1, the thick black circle indicates a bias toward the macrophage fate, and the bars indicate inhibition of these fates. Immunity 2002 16, 285-296DOI: (10.1016/S1074-7613(02)00277-7)

Figure 6 Switching PU.1-Expressing Progenitors from FTOC to HOS Conditions Can Result in Rescue into the Myeloid Lineage (A) FACS analysis of precursors expressing PU.1 and GFP or the LZRS-GFP (control) after 5 days in FTOC, gated on live cells. These lobes were then either switched to HOS conditions for 10 days or maintained in FTOC for an additional 5 days. Percentiles for each quadrant are indicated. These FACS plots represent pools of 3 lobes each for the PU.1 samples, and 1–2 lobes for the control GFP samples. (B) Diagrammatic representation of the experimental protocol showing the effects of PU.1 expression at each stage. Symbols are as in Figure 5. (C) Absolute numbers of GFP+ cells per lobe after 5 days in FTOC, 10 days in FTOC, or 10 days after the switch to HOS conditions (rescue). ND indicates not determined. Immunity 2002 16, 285-296DOI: (10.1016/S1074-7613(02)00277-7)

Figure 7 Ectopic PU.1 Expression Can Alter Gene Expression in Primary Thymocytes and the SCID.adh Cell Line (A) E14.5 fetal thymocytes were transduced with LZRS-GFP (control) or PU.1-GFP retroviral vectors, cultured for 24 hr in 25 ng/mL IL-7 and 2% stem cell factor, and analyzed by FACS. All flow cytograms are gated on live, GFP+ cells. CD115 indicates macrophage colony stimulating factor. (B) Absolute numbers of GFP+ cells per lobe for each phenotype category. (C) SCID.adh cells were transduced with control or PU.1-GFP retroviral vectors, cultured, and sorted on the basis of GFP and/or Mac-1 surface expression. This panel shows the relative values of mRNA levels for PU.1 in each sample as determined by real-time RT-PCR for three separate experiments. (D) Changes in mRNA levels in control-transduced SCID.adh cells, PU.1-transduced Mac-1− SCID.adh cells, and PU.1-transduced Mac-1+ SCID.adh cells in one representative experiment, as assessed by quantitative real-time PCR. The results are presented as ratios of PU.1+Mac-1−/Control (blue bars) and PU.1+Mac-1+/Control (red bars), on a logarithmic scale. Each set of relative values, calculated using a standard curve specific for each primer set, has been normalized to GAPDH mRNA levels. Immunity 2002 16, 285-296DOI: (10.1016/S1074-7613(02)00277-7)